DK162387A - Tumor-antigen, fremgangsmaade til fremstilling deraf samt anvendelse af antigenet til diagnose af humane tumorer - Google Patents

Tumor-antigen, fremgangsmaade til fremstilling deraf samt anvendelse af antigenet til diagnose af humane tumorer

Info

Publication number
DK162387A
DK162387A DK162387A DK162387A DK162387A DK 162387 A DK162387 A DK 162387A DK 162387 A DK162387 A DK 162387A DK 162387 A DK162387 A DK 162387A DK 162387 A DK162387 A DK 162387A
Authority
DK
Denmark
Prior art keywords
antigen
human tumor
diagnosis
preparing
disclosed
Prior art date
Application number
DK162387A
Other languages
Danish (da)
English (en)
Other versions
DK162387D0 (da
Inventor
Garth L Nicolson
Susan M North
Peter A Steck
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of DK162387D0 publication Critical patent/DK162387D0/da
Publication of DK162387A publication Critical patent/DK162387A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Communication Control (AREA)
  • Stereophonic System (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Prostheses (AREA)
  • Air Conditioning Control Device (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK162387A 1986-04-01 1987-03-31 Tumor-antigen, fremgangsmaade til fremstilling deraf samt anvendelse af antigenet til diagnose af humane tumorer DK162387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/846,938 US5030559A (en) 1986-04-01 1986-04-01 Methods and compositions for the identification of metastatic human tumors

Publications (2)

Publication Number Publication Date
DK162387D0 DK162387D0 (da) 1987-03-31
DK162387A true DK162387A (da) 1987-10-02

Family

ID=25299361

Family Applications (1)

Application Number Title Priority Date Filing Date
DK162387A DK162387A (da) 1986-04-01 1987-03-31 Tumor-antigen, fremgangsmaade til fremstilling deraf samt anvendelse af antigenet til diagnose af humane tumorer

Country Status (11)

Country Link
US (1) US5030559A (fr)
EP (1) EP0240341B1 (fr)
JP (1) JPH0742320B2 (fr)
AT (1) ATE105569T1 (fr)
AU (1) AU599364B2 (fr)
CA (1) CA1307478C (fr)
DE (1) DE3789781T2 (fr)
DK (1) DK162387A (fr)
ES (1) ES2051737T3 (fr)
FI (1) FI89806C (fr)
NO (1) NO175642C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930513A (en) * 1972-10-10 1976-01-06 Pius Buchegger Spray-cleaning apparatus

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648223A (en) * 1994-08-31 1997-07-15 Activated Cell Therapy, Inc. Methods for enriching breast tumor cells
US5663051A (en) * 1994-08-31 1997-09-02 Activated Cell Therapy, Inc. Separation apparatus and method
US5646004A (en) * 1994-08-31 1997-07-08 Activated Cell Therapy, Inc. Methods for enriching fetal cells from maternal body fluids
US5840502A (en) * 1994-08-31 1998-11-24 Activated Cell Therapy, Inc. Methods for enriching specific cell-types by density gradient centrifugation
DE19530272C1 (de) * 1995-08-17 1996-11-21 Univ Eberhard Karls Antikörper 103 B2
DE19530273C1 (de) * 1995-08-17 1996-12-12 Univ Eberhard Karls Antikörper 105A5
CA2429722A1 (fr) * 2000-11-28 2002-06-06 Wyeth Analyse de l'expression des acides nucleiques fkbp et polypeptides utiles dans le diagnostic et le traitement du cancer de la prostate
US20020142327A1 (en) * 2000-11-28 2002-10-03 Gillis Kimberly A. Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
US7037652B2 (en) * 2000-11-28 2006-05-02 Wyeth Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
US7169722B2 (en) * 2002-01-28 2007-01-30 Guardian Industries Corp. Clear glass composition with high visible transmittance
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
CN101511387A (zh) * 2006-09-08 2009-08-19 惠氏公司 使用亲和色谱法纯化蛋白质的精氨酸洗涤液
US10745701B2 (en) 2007-06-28 2020-08-18 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
US20090324596A1 (en) 2008-06-30 2009-12-31 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
WO2012177656A2 (fr) 2011-06-19 2012-12-27 Abogen, Inc. Dispositifs, solutions et procédés de recueillement d'échantillons
US12038434B2 (en) 2015-02-09 2024-07-16 DNA Genotek, Inc. Devices, solutions and methods for sample collection related applications, analysis and diagnosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697638A (en) * 1970-06-01 1972-10-10 Hoffmann La Roche Antigens
US4145336A (en) * 1976-04-30 1979-03-20 Scripps Clinic And Research Foundation Carcinoembryonic antigen isomer
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
IN150740B (fr) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4444744A (en) * 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
EP0160446B1 (fr) * 1984-05-01 1992-06-17 Ciba Corning Diagnostics Corp. Antigène associé aux tumeurs des seins et anticoprs monoclonaux spécifiques

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930513A (en) * 1972-10-10 1976-01-06 Pius Buchegger Spray-cleaning apparatus

Also Published As

Publication number Publication date
DK162387D0 (da) 1987-03-31
FI89806C (fi) 1993-11-25
JPH0742320B2 (ja) 1995-05-10
AU599364B2 (en) 1990-07-19
NO175642B (fr) 1994-08-01
CA1307478C (fr) 1992-09-15
FI871411L (fi) 1987-10-02
AU7075387A (en) 1987-10-08
EP0240341B1 (fr) 1994-05-11
FI871411A0 (fi) 1987-03-31
DE3789781T2 (de) 1994-11-10
FI89806B (fi) 1993-08-13
NO871352D0 (no) 1987-03-31
ATE105569T1 (de) 1994-05-15
NO871352L (no) 1987-10-02
EP0240341A2 (fr) 1987-10-07
DE3789781D1 (de) 1994-06-16
US5030559A (en) 1991-07-09
EP0240341A3 (en) 1989-07-19
NO175642C (no) 1994-11-09
JPS62253395A (ja) 1987-11-05
ES2051737T3 (es) 1994-07-01

Similar Documents

Publication Publication Date Title
DK162387A (da) Tumor-antigen, fremgangsmaade til fremstilling deraf samt anvendelse af antigenet til diagnose af humane tumorer
WO1998037418A3 (fr) Composes servant au diagnostic immunologique de cancer de la prostate et leurs procedes d'utilisation
EP0288082A3 (fr) Essai tumeur-spécifique pour le CA125 antigène du cancer ovarien
WO1999004265A8 (fr) Acides nucleiques et polypeptides associes au cancer
EP0378924A3 (fr) Détection de maladies ou dysfonctions neurologiques
WO1997033909A3 (fr) Composes et methodes d'immunotherapie et d'immunodiagnostic pour le cancer de la prostate
DE3751908D1 (de) Chimärisches Murine-Mensch-Immunoglobulin, spezifisch für tumorassoziertes 17-1A Antigen
EP0344940A3 (fr) Anticorps contre des protéines latentes de papillomavirus humain, systèmes de diagnostic et méthodes
WO1997008318A3 (fr) Composes et procedes de traitement et de diagnostic du cancer de la prostate
WO1989003846A3 (fr) Anticorps monoclonaux contre l'interleukine-4 humaine et hybridomes les produisant
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
DK314586A (da) Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler
DK172686A (da) Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
IE802533L (en) Cancer cell antigens
CA2294514A1 (fr) Procede d'identification d'antigenes de proteines cellulaires et de detection de la presence d'anticorps diriges contre des proteines cellulaires specifiques du serum
EP0218158A3 (fr) Anticorps monoclonal humain, lignée de cellules B pour la production de cet anticorps et méthode de préparation de cette lignée de cellules B et de cet anticorps.
EP0057236A4 (fr) Procede de determination d'une chaine laterale de glucose associee a une tumeur, procede de diagnostic de tumeurs, et "kit" pour diagnostiquer des tumeurs.
AU4194897A (en) Immunological composition for detection of bladder cancer and method of using same
OA08782A (en) Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies.
DK0809653T3 (da) Helicobacter pylori-antigen
OA08704A (en) Polypeptidic composition useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antimerozoite antibodies.
EP0275705A3 (fr) Anticorps monoclonaux spécifiques de cellules basales humaines, SCC et de cellules précancéreuses
DK0929812T3 (da) Diagnosehjælpemiddel samt fremgangsmåde til påvisning af drægtighed af drøvtyggere
Salinas et al. Antigenic heterogeneity as reflected by interaction with antibody (Ab) and circulating immune complexes (CIC) in sarcoma patients
FI875541A0 (fi) Foerfarande foer diagnos och testning av en anslutningsenhet.

Legal Events

Date Code Title Description
PBP Patent lapsed
AHB Application shelved due to non-payment